BK Polyomavirus Hijacks Extracellular Vesicles for <i>En Bloc</i> Transmission
Lynda Handala, Emmanuelle Blanchard, P. I. Raynal, Philippe Roingeard, Virginie Morel, Véronique Descamps, Sandrine Castelain, Catherine François, Gilles Duverlie, Étienne Brochot, François Helle
Abstract
Reactivation of BKPyV is responsible for nephropathies in kidney transplant recipients, which frequently lead to graft loss. The mechanisms of persistence and immune evasion used by this virus remain poorly understood, and a therapeutic option for transplant patients is still lacking. Here, we show that BKPyV can be released into EVs, enabling viral particles to infect cells using an alternative entry pathway. This provides a new view of BKPyV pathogenesis. Even though we did not find any decreased sensitivity to neutralizing antibodies when comparing EV-associated particles and naked virions, our study also raises important questions about developing prevention strategies based on the induction or administration of neutralizing antibodies. Deciphering this new release pathway could enable the identification of therapeutic targets to prevent BKPyV nephropathies. It could also lead to a better understanding of the pathophysiology of other polyomaviruses that are associated with human diseases.